{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T14:07:00Z","timestamp":1758809220599},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience Letters"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.neulet.2017.12.050","type":"journal-article","created":{"date-parts":[[2017,12,27]],"date-time":"2017-12-27T18:05:07Z","timestamp":1514397907000},"page":"148-152","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Serum Fetuin-A Levels in Patients with Bilateral Basal Ganglia Calcification"],"prefix":"10.1016","volume":"666","author":[{"given":"Bekir Enes","family":"Demiryurek","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asli Aksoy","family":"Gundogdu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neulet.2017.12.050_bib0005","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/mds.1049","article-title":"Bilateral striopallidodentate calcinosis: clinical characteristics of patients seen in a registry","volume":"16","author":"Manyam","year":"2001","journal-title":"Mov. Disord."},{"issue":"3","key":"10.1016\/j.neulet.2017.12.050_bib0010","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1212\/WNL.39.3.381","article-title":"Familial idiopathic striopallidodentate calcifications","volume":"39","author":"Ellie","year":"1989","journal-title":"Neurology"},{"key":"10.1016\/j.neulet.2017.12.050_bib0015","first-page":"129","article-title":"Idiopathische verkalkung der hirngef\u00e4sse","volume":"50","author":"Fahr","year":"1930","journal-title":"Zentralbl allg pathol"},{"key":"10.1016\/j.neulet.2017.12.050_bib0020","first-page":"430","article-title":"Clinical spectrum of bilateral striopallidodentat calcinosis","volume":"5","author":"Hanagas\u0131","year":"2004","journal-title":"Turk. J. Neurol."},{"issue":"590","key":"10.1016\/j.neulet.2017.12.050_bib0025","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.neulet.2015.01.047","article-title":"Serum fetuin-A levels in subjects with and without choroid plexus calcification","volume":"17","author":"Ceylan","year":"2015","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neulet.2017.12.050_bib0030","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.tcm.2007.02.005","article-title":"Vascular calcification and fetuin-A deficiency in chronic kidney disease","volume":"17","author":"Westenfeld","year":"2007","journal-title":"Trends Cardiovasc. Med."},{"key":"10.1016\/j.neulet.2017.12.050_bib0035","doi-asserted-by":"crossref","first-page":"227","DOI":"10.3109\/00207454.2011.642039","article-title":"Serum levels of calcification inhibitors in patients with intracranial hemorrhage","volume":"122","author":"Acar","year":"2012","journal-title":"Int. J. Neurosci."},{"key":"10.1016\/j.neulet.2017.12.050_bib0040","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.neulet.2005.06.014","article-title":"Genetic association of alpha2-Heremans-Schmid glycoprotein polymorphism with late-onset Alzheimer\u2019s disease in Italians","volume":"386","author":"Geroldi","year":"2005","journal-title":"Neurosci Lett"},{"issue":"11","key":"10.1016\/j.neulet.2017.12.050_bib0045","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1177\/1352458513477923","article-title":"Cerebrospinal fluid fetuin-A is a biomarker of active multiple sclerosis","volume":"19","author":"Harris","year":"2013","journal-title":"Mult. Scler."},{"key":"10.1016\/j.neulet.2017.12.050_bib0050","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/jcbfm.2009.247","article-title":"Peripheral administration of fetuin-A attenuates early cerebral ischemic injury in rats","volume":"30","author":"Wang","year":"2010","journal-title":"J. Cereb. Blood Flow Metab."},{"issue":"12","key":"10.1016\/j.neulet.2017.12.050_bib0055","doi-asserted-by":"crossref","first-page":"3532","DOI":"10.1002\/cam4.940","article-title":"Fetuin-A (alpha 2HS glycoprotein) modulates growth, motility, invasion, and senescence in high-grade astrocytomas","volume":"5","author":"Nangami","year":"2016","journal-title":"Cancer Med."},{"issue":"18","key":"10.1016\/j.neulet.2017.12.050_bib0060","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.2169\/internalmedicine.52.8375","article-title":"Extrapyramidal symptoms and advanced calcification of the basal ganglia in a patient with autosomal dominant hypocalcemia","volume":"52","author":"Kurozumi","year":"2013","journal-title":"Intern. Med."},{"key":"10.1016\/j.neulet.2017.12.050_bib0065","doi-asserted-by":"crossref","first-page":"124","DOI":"10.2174\/187221411799015372","article-title":"Fetuin-A a multifunctional protein","volume":"5","author":"Mori","year":"2011","journal-title":"Recent Pat. Endocr. Metab. Immune Drug Discov."},{"key":"10.1016\/j.neulet.2017.12.050_bib0070","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1042\/bj20030676","article-title":"Tissue distribution and activity testing suggest a similar but not identical function of fetuin-B and fetuin-A","volume":"376","author":"Denecke","year":"2003","journal-title":"Biochem. J."},{"key":"10.1016\/j.neulet.2017.12.050_bib0075","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/BF01239959","article-title":"A fetuin-related glycoprotein (alpha 2HS) in human embryonic and fetal development","volume":"248","author":"Dziegielewska","year":"1987","journal-title":"Cell Tissue Res."},{"issue":"5","key":"10.1016\/j.neulet.2017.12.050_bib0080","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1002\/dneu.22064","article-title":"Fetuin-A in the developing brain","volume":"73","author":"Elsas","year":"2013","journal-title":"Dev. Neurobiol."},{"key":"10.1016\/j.neulet.2017.12.050_bib0085","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1172\/JCI109551","article-title":"Serum concentration of human alpha 2 HS glycoprotein during the inflammatory process: evidence that alpha 2 HS glycoprotein is a negative acute-phase reactant","volume":"64","author":"Lebreton","year":"1979","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.neulet.2017.12.050_bib0090","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1172\/JCI17202","article-title":"The serum protein alpha 2-Heremans-Schmid glycoprotein\/fetuin-A is a systemically acting inhibitor of ectopic calcification","volume":"112","author":"Schafer","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.neulet.2017.12.050_bib0095","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.ejrad.2005.12.025","article-title":"Proatherogenic pathways leading to vascular calcification","volume":"57","author":"Mazzini","year":"2006","journal-title":"Eur. J. Radiol."},{"key":"10.1016\/j.neulet.2017.12.050_bib0100","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/S0140-6736(03)12710-9","article-title":"Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study","volume":"361","author":"Ketteler","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.neulet.2017.12.050_bib0105","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/nrurol.2015.34","article-title":"Prostate cancer: fetuin-A \u2013 a marker for metastatic disease?","volume":"12","author":"Stone","year":"2015","journal-title":"Nature Rev. Urol."},{"key":"10.1016\/j.neulet.2017.12.050_bib0110","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.pan.2013.03.010","article-title":"Profiling the potential tumor markers of pancreatic ductal adenocarcinoma using 2D-DIGE and MALDI-TOF- MS: up-regulation of complement C3 and alpha-2- HS- glycoprotein","volume":"13","author":"Chen","year":"2013","journal-title":"Pancreatology"},{"key":"10.1016\/j.neulet.2017.12.050_bib0115","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.yexcr.2013.12.003","article-title":"Alpha-2 Heremans Schmid Glycoprotein (AHSG) modulates signaling pathways in head and neck squamous cell carcinoma cell line SQ20B","volume":"321","author":"Thompson","year":"2014","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.neulet.2017.12.050_bib0120","doi-asserted-by":"crossref","first-page":"12755","DOI":"10.1074\/jbc.271.22.12755","article-title":"Fetuin\/alpha2-HS glycoprotein is a transforming growth factor-beta type II receptor mimic and cytokine antagonist","volume":"271","author":"Demetriou","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neulet.2017.12.050_bib0125","doi-asserted-by":"crossref","first-page":"19991","DOI":"10.1074\/jbc.M112234200","article-title":"Alpha 2-HS glycoprotein\/fetuin a transforming growth factor-beta\/bone morphogenetic protein antagonist, regulates postnatal bone growth and remodelling","volume":"277","author":"Szweras","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neulet.2017.12.050_bib0130","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.orthres.2004.11.010","article-title":"Regulation of BMP-induced ectopic bone formation by AHSG","volume":"23","author":"Rittenberg","year":"2005","journal-title":"J. Orthop. Res."},{"issue":"7","key":"10.1016\/j.neulet.2017.12.050_bib0135","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1177\/1352458507076406","article-title":"Cerebrospinal fluid proteome profile in multiple sclerosis","volume":"13","author":"Lehmensiek","year":"2007","journal-title":"Mult. Scler."},{"issue":"2","key":"10.1016\/j.neulet.2017.12.050_bib0140","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.neulet.2009.01.057","article-title":"CSF proteome analysis in clinically isolated syndrome (CIS): candidate markers for conversion to definite multiple sclerosis","volume":"452","author":"Tumani","year":"2009","journal-title":"Neurosci. Lett."},{"issue":"1","key":"10.1016\/j.neulet.2017.12.050_bib0145","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.nbd.2010.06.007","article-title":"Bri2-23 is a potential cerebrospinal fluid biomarker in multiple sclerosis","volume":"40","author":"Harris","year":"2010","journal-title":"Neurobiol. Dis."},{"issue":"6","key":"10.1016\/j.neulet.2017.12.050_bib0150","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.jprot.2010.01.004","article-title":"Multiple sclerosis: identification and clinical evaluation of novel CSF biomarkers","volume":"73","author":"Ottervald","year":"2010","journal-title":"J. Proteom."},{"issue":"4","key":"10.1016\/j.neulet.2017.12.050_bib0155","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/j.1468-1331.2009.02532.x","article-title":"The effects of natalizumab on inflammatory mediators in multiple sclerosis: prospects for treatment-sensitive biomarkers","volume":"16","author":"Khademi","year":"2009","journal-title":"Eur. J. Neurol."},{"issue":"2","key":"10.1016\/j.neulet.2017.12.050_bib0160","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s10072-013-1504-8","article-title":"Low fetuin-A level in migraine: a case-control study","volume":"35","author":"Tanriverdi","year":"2014","journal-title":"Neurol. Sci."},{"issue":"7","key":"10.1016\/j.neulet.2017.12.050_bib0165","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1177\/0003319713497421","article-title":"Associationbetween serum fetuin-A levels, carotid artery stiffness, and intima-mediathickness in patients with normotensive obstructive sleep apnea syndrome","volume":"65","author":"Akyuz","year":"2014","journal-title":"Angiology"},{"key":"10.1016\/j.neulet.2017.12.050_bib0170","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.atherosclerosis.2009.07.032","article-title":"Fetuin-A and CD40L plasma levels in acute ischemic stroke: differences in relation to TOAST subtype and correlation with clinical and laboratory variables","volume":"208","author":"Tuttolomondo","year":"2010","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.neulet.2017.12.050_bib0175","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1373\/clinchem.2013.212597","article-title":"Circulating fetuin-A and risk of ischemic stroke in women","volume":"60","author":"Jim\u00e9nez","year":"2014","journal-title":"Clin. Chem."},{"issue":"2","key":"10.1016\/j.neulet.2017.12.050_bib0180","doi-asserted-by":"crossref","first-page":"327","DOI":"10.3233\/JAD-2011-101872","article-title":"Plasma fetuin-A is associated with the severity of cognitive impairment in mild-to-moderate Alzheimer\u2019s disease","volume":"24","author":"Smith","year":"2011","journal-title":"J. Alzheimers Dis."},{"issue":"3","key":"10.1016\/j.neulet.2017.12.050_bib0185","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.neulet.2005.06.014","article-title":"Genetic association of alpha2-Heremans-Schmid glycoprotein polymorphism with late-onset Alzheimer\u2019s disease in Italians","volume":"7","author":"Geroldi","year":"2005","journal-title":"Neurosci. Lett."},{"issue":"3","key":"10.1016\/j.neulet.2017.12.050_bib0190","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1080\/01616412.2017.1281195","article-title":"Plasma protein profiling for potential biomarkers in the early diagnosis of Alzheimer\u2019s disease","volume":"39","author":"Kitamura","year":"2017","journal-title":"Neurol. Res."},{"issue":"2","key":"10.1016\/j.neulet.2017.12.050_bib0195","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1159\/000071082","article-title":"Elevated levels of alpha-2-Heremans-Schmid glycoprotein in CSF of patients with low-grade gliomas","volume":"24","author":"Ribom","year":"2003","journal-title":"Tumour Biol."}],"container-title":["Neuroscience Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394017310236?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394017310236?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,20]],"date-time":"2019-07-20T12:09:41Z","timestamp":1563624581000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304394017310236"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":39,"alternative-id":["S0304394017310236"],"URL":"https:\/\/doi.org\/10.1016\/j.neulet.2017.12.050","relation":{},"ISSN":["0304-3940"],"issn-type":[{"value":"0304-3940","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum Fetuin-A Levels in Patients with Bilateral Basal Ganglia Calcification","name":"articletitle","label":"Article Title"},{"value":"Neuroscience Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neulet.2017.12.050","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}